The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Doyle Anthony since 2020.
This trader's CIK number is 1808688.
At the time of last reporting, Doyle Anthony was the Chief Financial Officer of Biocryst Pharmaceuticals Inc. (stock ticker symbol BCRX).
Also see all insider trading activities at Biocryst Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | BCRX | 36,300 | $202,191 | 0 | $0 | 0 | $0 |
| 2021 | BCRX | 35,258 | $440,019 | 0 | $0 | 0 | $0 |
| 2020 | BCRX | 54,000 | $220,320 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-14 | BCRX | Buy | 36,300 | 5.57 | 202,191 |
| 2021-11-23 | BCRX | Buy | 35,258 | 12.48 | 440,019 |
| 2020-08-11 | BCRX | Buy | 54,000 | 4.08 | 220,320 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Doyle Anthony (Chief Financial Officer of Biocryst Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.